Cholinergic genetics of visual attention: Human and mouse choline transporter capacity variants influence distractibility

Journal of Physiology Paris

Volumn 110, Issue 1-2, 2016, Pages 10-18

  Sarter, Martin ^a   Lustig, Cindy ^a   Blakely, Randy D ^b   Koshy Cherian, Ajeesh ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b FLORIDA ATLANTIC UNIVERSITY   (United States)

Author keywords

Acetylcholine; Attention; Choline transporter; Genetics; Humans; Rodents

Indexed keywords

3' UNTRANSLATED REGION; BACTERIAL ARTIFICIAL CHROMOSOME; CHOLINERGIC SYSTEM; CHOLINERGIC TRANSMISSION; COGNITION; ENZYME ACTIVATION; GENETIC VARIATION; HUMAN; MEMORY; NEUROMODULATION; NONHUMAN; PROTEIN EXPRESSION; REVIEW; SELF REPORT; SINGLE NUCLEOTIDE POLYMORPHISM; VISUAL ATTENTION; ANIMAL; ATTENTION; GENETICS; METABOLISM; VISION;

ACETYLCHOLINE; CARRIER PROTEIN; CHOLINE TRANSPORTER;

ACETYLCHOLINE; ANIMALS; ATTENTION; GENETIC VARIATION; HUMANS; MEMBRANE TRANSPORT PROTEINS; VISUAL PERCEPTION;

EID: 84991256574     PISSN: 09284257     EISSN: 17697115     Source Type: Journal    
DOI: 10.1016/j.jphysparis.2016.07.001     Document Type: Review

References (85)

1. Apparsundaram, S., Martinez, V., Parikh, V., Kozak, R., Sarter, M., Increased capacity and density of choline transporters situated in synaptic membranes of the right medial prefrontal cortex of attentional task-performing rats. J. Neurosci. 25:15 (2005), 3851–3856.
2. Bazalakova, M.H., Blakely, R.D., 2006. The high-affinity choline transporter: a critical protein for sustaining cholinergic signaling as revealed in studies of genetically altered mice. Handbook Exp Pharmacol, vol. 175, pp. 525–544.
3. Bazalakova, M.H., Wright, J., Schneble, E.J., McDonald, M.P., Heilman, C.J., Levey, A.I., Blakely, R.D., Deficits in acetylcholine homeostasis, receptors and behaviors in choline transporter heterozygous mice. Genes Brain Behav. 6:5 (2007), 411–424.
4. Berry, A.S., Blakely, R.D., Sarter, M., Lustig, C., Cholinergic capacity mediates prefrontal engagement during challenges to attention: evidence from imaging genetics. Neuroimage 108 (2015), 386–395.
5. Berry, A.S., Demeter, E., Sabhapathy, S., English, B.A., Blakely, R.D., Sarter, M., Lustig, C., Disposed to distraction: genetic variation in the cholinergic system influences distractibility but not time-on-task effects. J. Cognitive Neurosci. 26:9 (2014), 1981–1991.
6. Berry, A.S., Li, X., Lin, Z., Lustig, C., Shared and distinct factors driving attention and temporal processing across modalities. Acta Psychol. (Amst) 147 (2014), 42–50.
7. Biss, R.K., Ngo, K.W.J., Hasher, L., Campbell, K.L., Rowe, G., Distraction can reduce age-related forgetting. Psychol. Sci. 24:4 (2013), 448–455.
8. Bucci, D.J., Holland, P.C., Gallagher, M., Removal of cholinergic input to rat posterior parietal cortex disrupts incremental processing of conditioned stimuli. J. Neurosci. 18:19 (1998), 8038–8046.
9. Buschman, T.J., Miller, E.K., Top-down versus bottom-up control of attention in the prefrontal and posterior parietal cortices. Science 315:5820 (2007), 1860–1862.
10. Connor, C.E., Egeth, H.E., Yantis, S., Visual attention: bottom-up versus top-down. Curr. Biol. 14:19 (2004), R850–R852.
11. Dani, J.A., Bertrand, D., Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system. Annu. Rev. Pharmacol. Toxicol. 47 (2007), 699–729.
12. Davidson, M.C., Cutrell, E.B., Marrocco, R.T., Scopolamine slows the orienting of attention in primates to cued visual targets. Psychopharmacology 142:1 (1999), 1–8.
13. Demeter, E., Guthrie, S.K., Taylor, S.F., Sarter, M., Lustig, C., Increased distractor vulnerability but preserved vigilance in patients with schizophrenia: evidence from a translational Sustained Attention Task. Schizophrenia Res. 144:1–3 (2013), 136–141.
14. Demeter, E., Hernandez-Garcia, L., Sarter, M., Lustig, C., Challenges to attention: a continuous arterial spin labeling (ASL) study of the effects of distraction on sustained attention. Neuroimage 54:2 (2011), 1518–1529.
15. Demeter, E., Sarter, M., Lustig, C., Rats and humans paying attention: cross-species task development for translational research. Neuropsychology 22:6 (2008), 787–799.
16. English, B.A., Hahn, M.K., Gizer, I.R., Mazei-Robison, M., Steele, A., Kurnik, D.M., Stein, M.A., Waldman, I.D., Blakely, R.D., Choline transporter gene variation is associated with attention-deficit hyperactivity disorder. J. Neurodev. Disorders 1:4 (2009), 252–263.
17. Ennis, E.A., Wright, J., Retzlaff, C.L., McManus, O.B., Lin, Z., Huang, X., Wu, M., Li, M., Daniels, J.S., Lindsley, C.W., Hopkins, C.R., Blakely, R.D., Identification and characterization of ML352: a novel, noncompetitive inhibitor of the presynaptic choline transporter. ACS Chem. Neurosci. 6:3 (2015), 417–427.
18. Everitt, B.J., Robbins, T.W., Central cholinergic systems and cognition. Annu. Rev. Psychol. 48 (1997), 649–684.
19. Ferguson, S.M., Bazalakova, M., Savchenko, V., Tapia, J.C., Wright, J., Blakely, R.D., Lethal impairment of cholinergic neurotransmission in hemicholinium-3-sensitive choline transporter knockout mice. Proc. Natl. Acad. Sci. USA 101:23 (2004), 8762–8767.
20. Ferguson, S.M., Blakely, R.D., The choline transporter resurfaces: new roles for synaptic vesicles?. Mol. Interventions 4:1 (2004), 22–37.
21. Ferguson, S.M., Savchenko, V., Apparsundaram, S., Zwick, M., Wright, J., Heilman, C.J., Yi, H., Levey, A.I., Blakely, R.D., Vesicular localization and activity-dependent trafficking of presynaptic choline transporters. J. Neurosci. 23:30 (2003), 9697–9709.
22. Gates, J. Jr., Ferguson, S.M., Blakely, R.D., Apparsundaram, S., Regulation of choline transporter surface expression and phosphorylation by protein kinase C and protein phosphatase 1/2A. J. Pharmacol. Exp. Ther. 310:2 (2004), 536–545.
23. Gill, T.M., Sarter, M., Givens, B., Sustained visual attention performance-associated prefrontal neuronal activity: evidence for cholinergic modulation. J. Neurosci. 20:12 (2000), 4745–4757.
24. Gritton, H.J., Howe, W.M., Mallory, C.S., Hetrick, V.L., Berke, J.D., Sarter, M., Cortical cholinergic signaling controls the detection of cues. Proc. Natl. Acad. Sci. USA 113:8 (2016), E1089–E1097.
25. Hahn, M.K., Blackford, J.U., Haman, K., Mazei-Robison, M., English, B.A., Prasad, H.C., Steele, A., Hazelwood, L., Fentress, H.M., Myers, R., Blakely, R.D., Sanders-Bush, E., Shelton, R., Multivariate permutation analysis associates multiple polymorphisms with subphenotypes of major depression. Genes Brain Behav. 7:4 (2008), 487–495.
26. Hasselmo, M.E., Neuromodulation: acetylcholine and memory consolidation. Trends Cognitive Sci. 3:9 (1999), 351–359.
27. Hasselmo, M.E., Sarter, M., Modes and models of forebrain cholinergic neuromodulation of cognition. Neuropsychopharmacology 36:1 (2011), 52–73.
28. Healey, M.K., Campbell, K.L., Hasher, L., Cognitive aging and increased distractibility: costs and potential benefits. Sossin, W.S., Lacaille, J.C., Castellucci, V.F., Belleville, S., (eds.) Essence of Memory, 2008, 353–363.
29. Holmstrand, E.C., Asafu-Adjei, J., Sampson, A.R., Blakely, R.D., Sesack, S.R., Ultrastructural localization of high-affinity choline transporter in the rat anteroventral thalamus and ventral tegmental area: differences in axon morphology and transporter distribution. J. Comp. Neurol. 518:11 (2010), 1908–1924.
30. Holmstrand, E.C., Lund, D., Cherian, A.K., Wright, J., Martin, R.F., Ennis, E.A., Stanwood, G.D., Sarter, M., Blakely, R.D., Transgenic overexpression of the presynaptic choline transporter elevates acetylcholine levels and augments motor endurance. Neurochem. Int. 73 (2014), 217–228.
31. Howe, W.M., Berry, A.S., Francois, J., Gilmour, G., Carp, J.M., Tricklebank, M., Lustig, C., Sarter, M., Prefrontal cholinergic mechanisms instigating shifts from monitoring for cues to cue-guided performance: converging electrochemical and fMRI evidence from rats and humans. J. Neurosci. 33:20 (2013), 8742–8752.
32. Howe, W.M., Gritton, H., Lusk, N., Berke, J.D., Sarter, M., Distinct behavioral and neurophysiological correlates of prefrontal acetylcholine and glutamate transients during attentional task performance. Soc. Neurosci. Abs., 2012 abstract # 913.906.
33. Howe, W.M., Ji, J., Parikh, V., Williams, S., Mocaër, E., Trocmé-Thibierge, C., Sarter, M., Enhancement of attentional performance by selective stimulation of alpha4beta2∗ nAChRs: underlying cholinergic mechanisms. Neuropsychopharmacology 35:6 (2010), 1391–1401.
34. Huba, G.J., Singer, J.L., Aneshensel, C.S., Antrobus, J.S., Short Imaginal Processes Inventory Manual. 1982, Research Psychologists Press, Post Huron, MI.
35. Isaacs, Y., Lin, Z., Deldin, P., Blakely, R., Sarter, M., Lustig, C., The “good” Choline Transporter Gene Variant? Resilience Against Distractibility and Depression. 2015, Society for Neuroscience Annual Meeting, Chicago, IL.
36. Klinkenberg, I., Blokland, A., The validity of scopolamine as a pharmacological model for cognitive impairment: a review of animal behavioral studies. Neurosci. Biobehav. Rev. 34:8 (2010), 1307–1350.
37. Kucinski, A., Koshy Cherian, A., Valuskova, P., Yegla, B., Parikh, V., Robinson, T., Sarter, M., Prone to Addiction as well as to Falls: Poor Attention in Sign-Tracking Rats Extends to Complex Movement Control and is Associated with Regression of Choline Transporter Capacity. 2015, Society for Neuroscience Annual Meeting, Chicago, IL.
38. Kus, L., Borys, E., Ping Chu, Y., Ferguson, S.M., Blakely, R.D., Emborg, M.E., Kordower, J.H., Levey, A.I., Mufson, E.J., Distribution of high affinity choline transporter immunoreactivity in the primate central nervous system. J. Comp. Neurol. 463:3 (2003), 341–357.
39. Lambe, E.K., Picciotto, M.R., Aghajanian, G.K., Nicotine induces glutamate release from thalamocortical terminals in prefrontal cortex. Neuropsychopharmacology 28:2 (2003), 216–225.
40. Langner, R., Eickhoff, S.B., Sustaining attention to simple tasks: a meta-analytic review of the neural mechanisms of vigilant attention. Psychol. Bull. 139:4 (2013), 870–900.
41. Lockman, P.R., Allen, D.D., The transport of choline. Drug Dev. Indust. Pharm. 28:7 (2002), 749–771.
42. Lustig, C., Jantz, T., Questions of age differences in interference control: when and how, not if?. Brain Res. 1612 (2015), 59–69.
43. Matthies, D.S., Fleming, P.A., Wilkes, D.M., Blakely, R.D., The Caenorhabditis elegans choline transporter CHO-1 sustains acetylcholine synthesis and motor function in an activity-dependent manner. J. Neurosci. 26:23 (2006), 6200–6212.
44. McGaughy, J., Kaiser, T., Sarter, M., Behavioral vigilance following infusions of 192 IgG-saporin into the basal forebrain: selectivity of the behavioral impairment and relation to cortical AChE-positive fiber density. Behav. Neurosci. 110:2 (1996), 247–265.
45. McGaughy, J., Sarter, M., Behavioral vigilance in rats: task validation and effects of age, amphetamine, and benzodiazepine receptor ligands. Psychopharmacology 117:3 (1995), 340–357.
46. Miller, B.T., D'Esposito, M., Searching for “the top” in top-down control. Neuron 48:4 (2005), 535–538.
47. Neigh, G.N., Arnold, H.M., Rabenstein, R.L., Sarter, M., Bruno, J.P., Neuronal activity in the nucleus accumbens is necessary for performance-related increases in cortical acetylcholine release. Neuroscience 123:3 (2004), 635–645.
48. Neumann, S.A., Brown, S.M., Ferrell, R.E., Flory, J.D., Manuck, S.B., Hariri, A.R., Human choline transporter gene variation is associated with corticolimbic reactivity and autonomic-cholinergic function. Biol. Psychiatry 60:10 (2006), 1155–1162.
49. Neumann, S.A., Lawrence, E.C., Jennings, J.R., Ferrell, R.E., Manuck, S.B., Heart rate variability is associated with polymorphic variation in the choline transporter gene. Psychosom. Med. 67:2 (2005), 168–171.
50. Neumann, S.A., Linder, K.J., Muldoon, M.F., Sutton-Tyrrell, K., Kline, C., Shrader, C.J., Lawrence, E.C., Ferrell, R.E., Manuck, S.B., Polymorphic variation in choline transporter gene (CHT1) is associated with early, subclinical measures of carotid atherosclerosis in humans. Int. J. Cardiovasc. Imaging 28:2 (2012), 243–250.
51. O'Connell, R.G., Dockree, P.M., Robertson, I.H., Bellgrove, M.A., Foxe, J.J., Kelly, S.P., Uncovering the neural signature of lapsing attention: electrophysiological signals predict errors up to 20 s before they occur. J. Neurosci. 29:26 (2009), 8604–8611.
52. Okuda, T., Haga, T., Functional characterization of the human high-affinity choline transporter. FEBS Lett. 484:2 (2000), 92–97.
53. Okuda, T., Haga, T., Kanai, Y., Endou, H., Ishihara, T., Katsura, I., Identification and characterization of the high-affinity choline transporter. Nat. Neurosci. 3:2 (2000), 120–125.
54. Okuda, T., Okamura, M., Kaitsuka, C., Haga, T., Gurwitz, D., Single nucleotide polymorphism of the human high affinity choline transporter alters transport rate. J. Biol. Chem. 277:47 (2002), 45315–45322.
55. Paolone, G., Angelakos, C.C., Meyer, P.J., Robinson, T.E., Sarter, M., Cholinergic control over attention in rats prone to attribute incentive salience to reward cues. J. Neurosci. 33:19 (2013), 8321–8335.
56. Paolone, G., Howe, W.M., Gopalakrishnan, M., Decker, M.W., Sarter, M., Regulation and function of the tonic component of cortical acetylcholine release. Westerink, B., Clinckers, R., Smolders, S., Sarre, S., Michotte, Y., (eds.) Monitoring Molecules in Neuroscience, 2010, Vrije Universiteit Brussels, Brussels, 363–365.
57. Parikh, V., Ji, J., Decker, M.W., Sarter, M., Prefrontal beta2 subunit-containing and alpha7 nicotinic acetylcholine receptors differentially control glutamatergic and cholinergic signaling. J. Neurosci. 30:9 (2010), 3518–3530.
58. Parikh, V., Kozak, R., Martinez, V., Sarter, M., Prefrontal acetylcholine release controls cue detection on multiple timescales. Neuron 56:1 (2007), 141–154.
59. Parikh, V., Man, K., Decker, M.W., Sarter, M., Glutamatergic contributions to nicotinic acetylcholine receptor agonist-evoked cholinergic transients in the prefrontal cortex. J. Neurosci. 28:14 (2008), 3769–3780.
60. Parikh, V., Sarter, M., Cortical choline transporter function measured in vivo using choline-sensitive microelectrodes: clearance of endogenous and exogenous choline and effects of removal of cholinergic terminals. J. Neurochem. 97:2 (2006), 488–503.
61. Parikh, V., Sarter, M., Cholinergic mediation of attention: contributions of phasic and tonic increases in prefrontal cholinergic activity. Ann. NY Acad. Sci. 1129 (2008), 225–235.
62. Parikh, V., St Peters, M., Blakely, R.D., Sarter, M., The presynaptic choline transporter imposes limits on sustained cortical acetylcholine release and attention. J. Neurosci. 33:6 (2013), 2326–2337.
63. Pinthong, M., Black, S.A.G., Ribeiro, F.M., Pholpramool, C., Ferguson, S.S.G., Rylett, R.J., Activity and subcellular trafficking of the sodium-coupled choline transporter CHT is regulated acutely by peroxynitrite. Mol. Pharmacol. 73:3 (2008), 801–812.
64. Poorthuis, R.B., Bloem, B., Schak, B., Wester, J., de Kock, C.P., Mansvelder, H.D., Layer-specific modulation of the prefrontal cortex by nicotinic acetylcholine receptors. Cerebral Cortex 23:1 (2013), 148–161.
65. Posner, M.I., Snyder, C.R.R., Davidson, B.J., Attention and the detection of signals. J. Exp. Psychol. Gen. 109:2 (1980), 160–174.
66. Ribeiro, F.M., Alves-Silva, J., Volknandt, W., Martins-Silva, C., Mahmud, H., Wilhelm, A., Gomez, M.V., Rylett, R.J., Ferguson, S.S.G., Prado, V.F., Prado, M.A.M., The hemicholinium-3 sensitive high affinity choline transporter is internalized by clathrin-mediated endocytosis and is present in endosomes and synaptic vesicles. J. Neurochem. 87:1 (2003), 136–146.
67. Ribeiro, F.M., Black, S.A., Prado, V.F., Rylett, R.J., Ferguson, S.S., Prado, M.A., The “ins” and “outs” of the high-affinity choline transporter CHT1. J. Neurochem. 97:1 (2006), 1–12.
68. Ribeiro, F.M., Black, S.A.G., Cregan, S.P., Prado, V.F., Prado, M.A.M., Rylett, R.J., Ferguson, S.S.G., Constitutive high-affinity choline transporter endocytosis is determined by a carboxyl-terminal tail dileucine motif. J. Neurochem. 94:1 (2005), 86–96.
69. Sarter, M., Behavioral-cognitive targets for cholinergic enhancement. Curr. Opinion Behav. Sci. 4 (2015), 22–26.
70. Sarter, M., Albin, R.L., Kucinski, A., Lustig, C., Where attention falls: increased risk of falls from the converging impact of cortical cholinergic and midbrain dopamine loss on striatal function. Exp. Neurol. 257 (2014), 120–129.
71. Sarter, M., Gehring, W.J., Kozak, R., More attention must be paid: the neurobiology of attentional effort. Brain Res. Rev. 51 (2006), 155–160.
72. Sarter, M., Givens, B., Bruno, J.P., The cognitive neuroscience of sustained attention: where top-down meets bottom-up. Brain Res. Rev. 35:2 (2001), 146–160.
73. Sarter, M., Kim, Y., Interpreting chemical neurotransmission in vivo: techniques, time scales, and theories. ACS Chem. Neurosci. 6:1 (2015), 8–10.
74. Sarter, M., Lustig, C., Berry, A.S., Gritton, H., Howe, W.M., Parikh, V., What do phasic cholinergic signals do?. Neurobiol. Learn. Memory 130 (2016), 135–141.
75. Sarter, M., Lustig, C., Blakely, R.D., Koshy Cherian, A., Valuskova, P., Parikh, V., Kim, Y., Tronson, N.C., Ennis, E.A., Super-Cholinergic Mice and Humans: Cholinergic-Cognitive-Affective Resiliencies. 2015, ACNP Annual Meeting, Hollywood, FL.
76. Sarter, M., Lustig, C., Howe, W.M., Gritton, H., Berry, A.S., Deterministic functions of cortical acetylcholine. Eur. J. Neurosci. 39:11 (2014), 1912–1920.
77. Sarter, M., Parikh, V., Choline transporters, cholinergic transmission and cognition. Nat. Rev. Neurosci. 6:1 (2005), 48–56.
78. Simon, J.R., Atweh, S., Kuhar, M.J., Sodium-dependent high affinity choline uptake: a regulatory step in the synthesis of acetylcholine. J. Neurochem. 26:5 (1976), 909–922.
79. St Peters, M., Cherian, A.K., Bradshaw, M., Sarter, M., Sustained attention in mice: expanding the translational utility of the SAT by incorporating the Michigan Controlled Access Response Port (MICARP). Behav. Brain Res. 225:2 (2011), 574–583.
80. St Peters, M., Demeter, E., Lustig, C., Bruno, J.P., Sarter, M., Enhanced control of attention by stimulating mesolimbic-corticopetal cholinergic circuitry. J. Neurosci. 31:26 (2011), 9760–9771.
81. Steelman, K.S., McCarley, J.S., Wickens, C.D., Great expectations: top-down attention modulates the costs of clutter and eccentricity. J. Exp. Psychol. Appl. 19:4 (2013), 403–419.
82. Thiele, A., Muscarinic signaling in the brain. Annu. Rev. Neurosci. 36:1 (2013), 271–294.
83. Valuskova, P., Koshy Cherian, A., Pitchers, K., Kim, Y., Lindsley, C., Ennis, E., Blakely, R.R., Sarter, M., Negative Modulation of Choline Transporter (CHT) Function Reveals Superior Cholinergic Capacity of CHT-Overexpressors. 2015, Society for Neuroscience Annual Meeting, Chicago, IL.
84. Walther, D.B., Fei-Fei, L., Task-set switching with natural scenes: measuring the cost of deploying top-down attention. J. Vis., 7(11), 2007 9 1-12.
85. White, H.A., Shah, P., Uninhibited imaginations: creativity in adults with attention-deficit/hyperactivity disorder. Personality Individual Differences 40:6 (2006), 1121–1131.